~~<i id='D4BAEE54F5'><strike id='D4BAEE54F5'><tt id='D4BAEE54F5'><pre id='D4BAEE54F5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：focus 2025-09-30 09:30:06 - browse：8922

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Meta's Zuckerberg and Chan on track to put $50 billion into science

focus

knowledge

entertainment

Wikipedia

leisure time

focus

OutgoingBristolCEOGiovanniCaforioEmiliePickeringforSTATIt’schangingoftheguardtimeatpharmaceuticalgia

WSS

Health Care Service Corp to buy Cigna Medicare Advantage plans

Maker of FluMist seeks to allow at

Senate panel to vote on hospitals, PBMs, prisoner care

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

First Opinion Podcast: How to protect health care in times of war

Testing for cancer recurrence creates a new limbo for patients

focus

fashion

focus

Continuity nursing helped my family in our darkest PICU moments

Syphilis numbers in the United States reach record heights

What does generative AI mean for health care? We asked experts

Cassava reveals details — and problems — with Alzheimer's study

Anesthesiologist group: stop taking Ozempic before surgery

Emergency medicine has repudiated 'excited delirium.' Now what?

Medicare details structure of new drug price negotiation program

Telehealth options flood the market as retailers push virtual care

Hepatitis C has a cure — but many Americans still lack access to it

The FDA weighs the risks of candy

knowledge

Wegovy leads to weight loss. Can it treat depression, too?

Why you shouldn’t ask, “What country has the best health care?”

Hospitals warn Medicare's drug payment fix is ‘unlawful’

How generative AI ratchets up security threats for health systems

Boston competes with Raleigh

The Affordable Care Act has saved billions in health care costs

entertainment

Wikipedia

leisure time

focus